Abstract:Hepatitis E virus (HEV) causes liver disease in humans and is thought to be a zoonotic infection, with domestic animals, including swine and rabbits, being a reservoir. One of the proteins encoded by the virus is the capsid protein. This is likely the major immune-dominant protein and a target for vaccination. Four monoclonal antibodies (MAbs), three novel, 1E4, 2C7, and 2G9, and one previously characterized, 1B5, were evaluated for binding to the capsid protein from genotype 4 swine HEV. The results indicated that 625DFCP628, 458PSRPF462, and 407EPTV410 peptides on the capsid protein comprised minimal amino acid sequence motifs recognized by 1E4, 2C7, and 2G9, respectively. The data suggested that 2C7 and 2G9 epitopes were partially exposed on the surface of the capsid protein. Truncated genotype 4 swine HEV capsid protein (sp239, amino acids 368 to 606) can exist in multimeric forms. Preincubation of swine HEV with 2C7, 2G9, or 1B5 before addition to HepG2 cells partially blocked sp239 cell binding and inhibited swine HEV infection. The study indicated that 2C7, 2G9, and 1B5 partially blocked swine HEV infection of rabbits better than 1E4 or normal mouse IgG. The cross-reactivity of antibodies suggested that capsid epitopes recognized by 2C7 and 2G9 are common to HEV strains infecting most host species. Collectively, MAbs 2C7, 2G9, and 1B5 were shown to recognize three novel linear neutralizing B-cell epitopes of genotype 4 HEV capsid protein. These results enhance understanding of HEV capsid protein structure to guide vaccine and antiviral design.IMPORTANCE Genotype 3 and 4 HEVs are zoonotic viruses. Here, genotype 4 HEV was studied due to its prevalence in human populations and pig herds in China. To improve HEV disease diagnosis and prevention, a better understanding of the antigenic structure and neutralizing epitopes of HEV capsid protein are needed. In this study, the locations of three novel linear B-cell recognition epitopes within genotype 4 swine HEV capsid protein were characterized. Moreover, the neutralizing abilities of three MAbs specific for this protein, 2C7, 2G9, and 1B5, were studied in vitro and in vivo Collectively, these findings reveal structural details of genotype 4 HEV capsid protein and should facilitate development of applications for the design of vaccines and antiviral drugs for broader prevention, detection, and treatment of HEV infection of diverse human and animal hosts.

Characterization of Antibody Responses Against a Neutralizing Epitope on the Glycoprotein E2 of Classical Swine Fever Virus

Hypervariable Antigenic Region 1 of Classical Swine Fever Virus E2 Protein Impacts Antibody Neutralization.

The Epitope Recognized by Monoclonal Antibody 2B6 in the B/C Domains of Classical Swine Fever Virus Glycoprotein E2 Affects Viral Binding to Hyperimmune Sera and Replication.

Candidate Vaccine Focused on a Classical Swine Fever Virus Epitope Induced Antibodies with Neutralizing Activity.

jmbReview The Epitope Recognized by Monoclonal Antibody 2 B 6 in the B / C Domains of Classical Swine Fever Virus Glycoprotein E 2 Affects Viral Binding to Hyperimmune Sera and Replication

Spying the neutralizing epitopes on E2 N-terminal by candidate epitope-vaccines against classical swine fever virus.

The Protective Immune Response Induced by B Cell Epitope of Classical Swine Fever Virus Glycoprotein E2

Identification of neutralizing epitopes on the D/A domain of the E2 glycoprotein of classical swine fever virus

Expression and Characterization of a Recombinant Porcinized Antibody Against the E2 Protein of Classical Swine Fever Virus

Generation and epitope mapping of novel neutralizing monoclonal antibodies against glycoprotein E2 of CSFV

Characterization of monoclonal antibodies that specifically differentiate field isolates from vaccine strains of classical swine fever virus

Characterization of Three Novel Linear Neutralizing B-Cell Epitopes in the Capsid Protein of Swine Hepatitis E Virus

A novel linear epitope at the C-terminal region of the classical swine fever virus E2 protein elicits neutralizing activity

E2 and E rns of classical swine fever virus C-strain play central roles in its adaptation to rabbits

Genetic Characterization of E2 Gene of Classical Swine Fever Virus by Restriction Fragment Length Polymorphism and Phylogenetic Analysis.

Multiple Linear B-cell Epitopes of Classical Swine Fever Virus Glycoprotein E2 Expressed in E.coli As Multiple Epitope Vaccine Induces a Protective Immune Response

Broad neutralization of CSFV with novel monoclonal antibodies in vivo

Genetic Diversity of the Envelope Glycoprotein E2 of Classical Swine Fever Virus: Recent Isolates Branched Away from Historical and Vaccine Strains.

Antigenic analysis of classical swine fever virus E2 glycoprotein using pig antibodies identifies residues contributing to antigenic variation of the vaccine C-strain and group 2 strains circulating in China

Antigens Containing TAVSPTTLR Tandem Repeats Could Be Used in Assaying Antibodies to Classical Swine Fever Virus.

[Expression and Antiviral Activity of a Chimeric Porcinized Monoclonal Antibody (chq06) Against E2 Protein of Classical Swine Fever Virus].